Background/Purpose: Patients with neurologic complaints are imaged with MRI protocols that may include many pulse sequences. It has not been documented which sequences are essential. We assessed the diagnostic accuracy of a limited number of sequences in patients with new neurologic complaints.
Introduction
Diagnostic medical imaging is one of the major driving forces behind rising healthcare expenditures. Between 2000 and 2006, Medicare spending on imaging services more than doubled, increasing to $14 billion 1 . The volume of brain MR studies performed may continue to rise in the future due to the expansion of health care insurance under the Patient Protection and Affordable Care Act (PPACA) and as a result of an aging population. At our institution, patients with various neurologic complaints are often imaged with MRI protocols that may involve a large number of pulse sequences, resulting in long scan times. There have been major advances in MRI hardware and software technology since the days of the first nuclear magnetic resonance (NMR) images in 1974. These advancements have provided us with an array of available MR sequences to choose from for our neuroimaging protocols. Long scan times related to multiple sequence acquisitions likely result in patient inconvenience and discomfort. It is unclear whether the multiple MR sequences performed are necessary and which of the sequences add value to the interpretation of the study. Optimizing the number of sequences in a routine screening brain MR protocol could improve efficiency as well as increase patient compliance and satisfaction by reducing scan time. Our goal was to investigate the diagnostic accuracy of brain MRI protocols containing a limited number of basic sequences in the evaluation of patients with new neurologic complaints.
Methods

Patient Selection
This retrospective study was approved by the Partners Human Research Committee, our hospital's Institutional Review Board (IRB). Consent was not obtained and patient records/information was anonymized and de-identified prior to analysis.
We performed a retrospective study of consecutive brain MR examinations performed at our institution, a major urban academic medical center, between February 20, 2010 and April 21, 2010 . Studies included patients of all ages who underwent brain MR imaging for the evaluation of new neurologic complaints for which there was no established diagnosis stated on the radiology requisition. We included studies referred from the emergency department, inpatient and outpatient settings. Both intravenous contrast-enhanced and unenhanced studies were included as were studies that contained MR angiogram (MRA) and MR venogram (MRV) sequences. Image review commenced in June 2012, at least 24 months after the examinations were performed. Exclusion criteria were MR studies performed for follow-up evaluation of pre-existing neurological conditions (e.g. serial neuro-oncology studies) and specialized MR protocols (e.g. pituitary, orbits, brainstem and internal auditory canal studies).
All MRI examinations were performed on either 1.5T (Tesla) or 3T MR systems (GE Healthcare Clinical Systems, Wauwatosa, WI, USA; Siemens Medical Solutions, Erlangen, Germany). A total of 9 MRI scanners were used during the period that was reviewed. Eight scanners had field strengths of 1.5T. Six were manufactured by General Electric; 3 were located within the hospital and 3 were located at free standing imaging centers. Two 1.5T MRI scanners were manufactured by Siemens and were located within the hospital. Additionally, a single Siemens 3T scanner was located within the hospital. All MR images in the study were reviewed on a PACS system (Agfa Impax 5.3, Agfa Healthcare, Mortsel, Belgium).
Study Interpretation
The total number of consecutive MRI studies was partitioned into two separate data sets (group 1, MR studies from The group 1 neuroradiologists reviewed a three-sequence abbreviated image set composed of sagittal T1-weighted images, axial T2-weighted FLAIR images, and images derived from a single diffusion-weighted imaging sequence, which included images with and without diffusion gradients, as well as derived apparent diffusion coefficient maps. The neuroradiologists interpreted those three MRI sequences while blinded to both the additional MRI sequences that were acquired, and to the official radiologic report. For each case, a group 1 neuroradiologist formulated an impression based on the three limited sequences and then subsequently compared it to the unblinded impression in the reference official radiologic report. For any discrepancy between the two interpretations, the neuroradiologist was instructed to revisit the limited MR sequences and determine whether, in retrospect, the discrepant findings could have been made on the limited sequences, but were missed due to perceptual error. The second phase of the study involved a different set of staff neuroradiologists with experience ranging from 2 to 20 years. The group 2 neuroradiologists reviewed a four-sequence abbreviated image set composed of the three basic sequences that were reviewed by the group 1 neuroradiologists, with the addition of an axial magnetic susceptibility sensitive sequence (either T2* gradient recalled echo (GRE), or susceptibility weighted imaging (SWI), including susceptibility weighted angiography (SWAN)). The neuroradiologists interpreted those four MRI sequences while blinded to both the additional MRI sequences that were acquired, and to the official radiologic report. For each case, a group 2 neuroradiologist formulated an impression based on the four limited sequences and then subsequently compared it to the unblinded impression in the official radiologic report, (the reference standard). For any discrepancy between the two interpretations, the neuroradiologist revisited the limited MR sequences and determined whether, in retrospect, the discrepant findings could have been appreciated on the limited sequences, but were missed due to perceptual error.
The limited sequence interpretations by the neuroradiologists in groups 1 and 2 were performed on the same PACS workstations as the original interpretations, and they are located in the same interpretation areas as in the original clinical interpretation. The only history that was permitted to the new study reviewer was the limited one provided with the original request for imaging. The neuroradiologists in groups 1 and 2 were allowed to review previous MRI studies when available, but only the limited MRI sequences on the prior study could be reviewed when formulating an impression. Readers in both groups were not permitted to review post-contrast, MRA, or MRV images, if these were acquired.
In order to eliminate recall bias, the assignment of MRI cases to each neuroradiologist was reviewed. If any case had been previously reviewed by the neuroradiologist to which the case was assigned, then the case was reassigned to an additional neuroradiologist (RGG) who reviewed the case with the same instructions.
We designated findings and discrepancies as major if they were likely to have a significant impact on patient management. Level 1 findings were designated as those requiring immediate communication at our institution: acute infarction, intracranial hemorrhage and unexpected mass lesion. The following imaging findings were also designated as major: subacute infarctions; posterior reversible encephalopathy syndrome (PRES); vascular malformations; malformations of cortical development (including focal cortical dysplasia); hydrocephalus; parenchymal lesions suspicious for infection, inflammatory disease, primary or secondary CNS neoplasm; and other mass lesions. Abnormalities of the major intracranial flow voids including arterial dissection, venous sinus thrombosis and intra-arterial thrombus were also considered major abnormalities. Acute/subacute infarctions required observation of decreased diffusivity in DWI sequences. Microhemorrhages (punctate parenchymal foci of susceptibility effect) were considered potentially important findings. Other typically incidental findings were designated as non-major.
Statistical Analysis
A descriptive analysis of the data from groups 1 and 2 was performed.
Results
Out of a total of ,3750 brain MRI studies, 998 brain MRI studies met our eligibility criteria. The first 497 studies were placed in group 1, and the remaining 499 in group 2.
In group 1, 84 major findings were identified (16.9% of studies, Table 1 ). All 41 level 1 findings (28 acute infarcts, 9 hemorrhages, and 4 mass lesions) were identified on the limited sequences. Examples of cases with accurately interpreted major findings included traumatic brain injury with multi-compartment intracranial hemorrhages ( Figure 1 ) and neoplasms ( Figure 2 ). Of these 84 major findings, there were 21 discrepancies between the interpretation based on the abbreviated MRI protocol, and the official interpretation from the radiologic report, yielding an error rate of 25.0%.
The most common discrepant major findings were enhancing intracranial lesions (12 cases) ( Figure 3 ). There were 4 small acute or subacute infarctions that were missed by two of the group 1 readers. All of these abnormalities were identified on the diffusion MR sequences when the readers re-examined these studies. Thus, Sagittal T1-weighted image (E) shows no definite abnormality. Axial FLAIR image (F) demonstrates asymmetric cortical thickening, gyral enlargement within the right frontal and parietal lobes without restricted diffusion on the axial diffusion weighted trace (G) image, consistent with pachygyria. Coronal FLAIR image (H) reveals asymmetric cortical thickening, abnormal sulcation and white matter signal hyperintensity in the right parietal lobe. The group 1 reader described the right frontal lobe signal abnormality, but did not diagnose the full extent of the hemispheric abnormality. These findings are more apparent on the coronal FLAIR sequence, not available to the reader. doi:10.1371/journal.pone.0110803.g004 these discrepancies were due to perceptual error. The diagnosis of cortical dysplasia was not made in 2 studies by group 1 readers. Abnormalities on the limited sequences were identified (Figure 4 ), but the diagnosis was not suggested. In the other case, a small nonenhancing lesion was only observed upon repeat review of the study (Figures 5) .
There were 3 vascular abnormalities that were not identified on the abbreviated sequences; 2 cases of middle cerebral artery branch (MCA) thrombus in patients with concurrent acute infarctions and a case of transverse sinus thrombosis. The cases of MCA branch occlusion were not visualized on the 3-sequence series, although the acute infarctions in the MCA distribution were identified. The group 1 reader who did not identify the venous thrombosis reported that they would not have seen this lesion without an MR venogram.
In group 1, there were 19 cases that had evidence of probable microhemorrhage (3.8%). Out of these 19 cases, 15 were not identified by group 1 readers on the abbreviated MR sequences (77.8%) (Figure 6 ).
In the group 2 evaluation, there were 117 major findings in the 499 MR studies (23.4%, Table 2 ). Examples of cases with accurately detected major findings included early infarctions (Figures 7, 8 , and 9) and neoplasms ( Figure 10 ). Of these, 19 major findings were not identified on the abbreviated 4-sequence MRI series resulting in an error rate of 16.2%. Enhancing parenchymal lesions were the most commonly missed major findings (17 cases). The other major discrepancies were vascular lesions; one case of ICA dissection ( Figure 11 ) and one case of vertebrobasilar arterial occlusion (Figure 12 ). In both of these cases, the readers reported that the absence of the flow voids was not identifiable without the aid of a non-inversion recovery T2-weighted sequence or MR angiogram ( Figures 11D-F and 12E-G ). There were 28 cases with probable microhemorrhages in the group 2 data set. All of these were identified by the group 2 readers.
Discussion
Since the introduction of MRI for the clinical evaluation of brain pathology, a large number of pulse sequences have been developed, and those with the highest clinical value have been extensively evaluated. However, there is little documented research on the optimal set of MRI sequences for the evaluation of patients with specific clinical presentations. In this evaluation of MRI used in patients with a new neurological complaint, we found that a limited-sequence imaging protocol can identify nearly all significant brain abnormalities with the major exceptions of small, Figure 5 . Cortical dysplasia versus dysembryoplastic neuroepithelial tumor in an 18 year old male with seizures. Sagittal T1-weighted image (A) shows no definite abnormality. Axial T2-weighted FLAIR image (B) demonstrates a subtle focal area of signal hyperintensity within the cortex and subcortical white matter of the left parafalcine parietal lobe(white arrow) with no corresponding restricted diffusion on the axial diffusion weighted trace (C) image. Axial T2-weighted image (D) again demonstrates the hyperintense lesion within the cortex and subcortical white matter of the left parafalcine parietal lobe (white arrow), which is compatible with cortical dysplasia or dysembryoplastic neuroepithelial tumor. This finding is subtle and was not seen prospectively when using the limited sequences. However, the lesion can be seen on the FLAIR images in retrospect. Furthermore, for seizure patients, additional sequences, including isotropic multiplanar sequences, could be added that would help in identifying subtle abnormalities. doi:10.1371/journal.pone.0110803.g005 Figure 6 . Cerebral amyloid angiopathy in a 78 year old female with altered mental status. Sagittal T1-weighted image (A) shows age appropriate parenchymal volume loss. Axial FLAIR image (B) demonstrates a small number of nonspecific hyperintense foci that are not unusual in a patient of this age. The axial diffusion weighted image (C) demonstrates no evidence of acute ischemia. Sequences A-C (group 1 sequences) show no definite abnormality that would explain the patient's symptoms. Axial gradient recalled echo image (D) reveals multiple punctate foci of susceptibility effect (white arrows) involving peripheral grey-white matter junctions, consistent with chronic microhemorrhages, which was not identified by the group 1 reader. This sequence alone (in addition to the other 3 sequences) provides the information needed to make the diagnosis of cerebral amyloid angiopathy. doi:10.1371/journal.pone.0110803.g006 contrast-enhancing lesions and vascular lesions that are revealed by MR angiography. The 4-sequence protocol was superior to the 3-sequence protocol due to improved detection of probable microhemorrhages, and we conclude that it is sufficiently robust for the routine evaluation of patients who have new neurological symptoms and do not have a clear clinical indication for the use of contrast (e.g. history of a primary non-CNS malignancy or suspicion of demyelinating/inflammatory disorders) or direct evaluation of the cerebral vasculature (e.g. vascular risk factors with high suspicion for acute ischemia).
The T2-weighted FLAIR sequence has been shown to be the single most sensitive sequence for the detection of brain pathology [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Saleh et al. demonstrated in 1026 consecutive outpatient MRI studies that this sequence alone had positive and negative predictive values of 96.1% and 98.4%, respectively, for lesions detectable by a complete MRI protocol that included contrast enhancement [17] . The data presented here are fully consistent with this work. However, the T2-weighted FLAIR sequence is not sensitive in detecting small enhancing lesions, small structural lesions, early ischemia, and microhemorrhages, and it cannot be relied upon as the only sequence. The use of diffusion MRI and susceptibility sequences are excellent supplemental sequences for the detection of the latter two types of abnormalities.
Cerebral microhemorrhages are a common finding, but have indeterminate prognostic and therapeutic significance [18] . Using the 3-sequence protocol, 78% of cases with probable cerebral microhemorrhages were undetected by readers viewing the T1, T2-weighted FLAIR and diffusion sequences. This is similar to prior reports [19, 20] . All probable microhemorrhages were correctly identified by readers who were able to view an axial susceptibility sequence as part of the 4 sequence protocol. This finding is consistent with the known superiority of susceptibilityweighted sequences in identifying small foci of susceptibility effect [18] [19] [20] [21] [22] [23] .
The use of the 3-sequence protocol resulted in lack of detection of 25% of major abnormalities, with over half of these being enhancing lesions. An improved detection rate was manifest with the 4-sequence protocol, with a lack of detection of 16% of major findings, but 90% of these were enhancing lesions. Enhancing lesions included meningiomas, active inflammatory/demyelinating lesions, metastases and probable primary brain tumors, as well as indeterminate punctate areas of parenchymal enhancement. Our findings suggest that intravenous gadolinium-based contrast should be administered in patients with a history of malignancy or suspected demyelinating/inflammatory disorders. Several significant vascular lesions were not identified on the 3-or 4-sequence protocols, even upon revisiting the study, but were identified on MRA or MRV. Two of the missed vascular abnormalities in group 1 were occlusions in MCA branches. In cases where arterial dissection, vascular thrombosis or occlusion is clinically suspected, a vascular imaging sequence such as an MRA or MRV may add considerable value ( Figures 11D-F and 12E-G) .
One case of cortical dysplasia in group 1 was not initially identified, but the dysplasia was discernible in retrospect ( Figure 5 ). The finding is subtle but visible on FLAIR images, and more obvious on T2 images. In these patients with a history of seizures, additional sequences could be added to the protocol for diagnostic imaging, including the use of high resolution, isotropic multiplanar sequences that would aid in identifying the structural abnormalities that may often be subtle.
The limited 4-sequence MRI protocol should increase efficiency and reduce scan length. The amount of time saved using the 4-sequence protocol is difficult to precisely calculate due to the variable pre-scan preparation times; however, we estimate that the time saved ranges from 5 to 25 minutes per study compared to our standard protocols. Further efficiencies in study acquisition may be possible through optimization of the limited sequence parameters. Also, substantial time savings in the interpretation of the 4-sequence MRI studies are expected since there will be fewer images per study for the neuroradiologist to review.
The 4-sequence MRI protocol will only be efficient and of value if the limited sequences allow the neuroradiologist to make a correct diagnosis with a limited rate of patient recall for additional sequences. The data in our study suggest that the patient recall rate will be very low and on the order of ''misses'' using the standard protocol.
A proper review of the patient's history should allow the neuroradiologist to tailor the MRI sequences to be performed for any given indication. The limited 4-sequence MRI screening protocol is only appropriate for the patient with new neurological complaints without an existing diagnosis. For example, a patient with known metastatic cancer will receive a contrast-enhanced MRI study. For patients undergoing the limited screening protocol, unexpected findings may be detected that warrant work-up with additional MR sequences. In these cases, we envision a hybrid solution. A large number of cases are monitored in 'real-time' by the neuroradiologist, which allows for immediate tailoring of the examination based on the findings on the limited sequences. Current technology even permits the neuroradiologist to remotely monitor cases and tailor them off-site. However, there will be some cases that cannot be monitored and such patients may require additional sequences to be performed at another time.
This study has several limitations. It has a retrospective design, although effort was made to minimize bias by analyzing consecutive cases. Despite our diligent attempt to minimize bias, results should be interpreted with caution as they have not yet been validated in a prospective fashion or using active clinical cases. A prospective study is currently being designed to confirm the findings described here. An additional limitation is that the impressions from each original MRI interpretation were used as the reference standard. There may have been findings on brain MRI that were mentioned only in the body of a report and not in the impression. This most notably occurred in patients with probable microhemorrhages. Another limitation is that the original MRI interpretations were performed in the true clinical setting where the neuroradiologist may have been interrupted or distracted by phone calls, teaching and consultations, which is different than the clinical research conditions under which the group 1 and 2 neuroradiologists reviewed the cases. However, the group 1 and 2 neuroradiologsists interpreted their cases using the same PACS workstations in the same clinical work areas as those of the original interpretations and, therefore, were subject to similar disturbances and distractions. In addition, for the original clinical interpretations, the readers also had access to the full medical record that is readily accessible at the workstation, as well as the ability to contact the referring the physician for further information. Thus the reading of the limited sequences was more restricted than the original reading, thus providing an added measure of assurance on the validity of the results. The heterogeneity of our institutions MRI scanners, which had different manufacturers and field strengths, may be considered as another limitation. Bearing that in mind, the national installed base of clinical magnets has far greater heterogeneity than our institutions and one might argue that these studies cannot reflect the diversity of clinical practice. Additionally, this paper describes an effort to limit the number of sequences required for routine performance and is not making any comment with respect to interpretation times. Finally, the readers were primarily experienced neuroradiologists, which is not necessarily true for all those interpreting brain MRIs. We have not attempted to validate error rates utilizing this protocol amongst general radiologists or other specialists.
Conclusions
A four-sequence MRI protocol that includes sagittal T1 weighted images, axial T2-weighted FLAIR images, axial diffusion-weighted images, and T2*-weighted images reliably detects nearly all non-enhancing brain MRI findings in patients without a known history of a neurologic disease undergoing evaluation for a new neurologic complaint. If a patient has persistent unexplained symptoms, an additional MRI study including post-contrast and high-resolution imaging should reveal abnormalities characterized by blood brain barrier breakdown or small structural lesions. Clinical information suggesting a vascular lesion should be evaluated using an angiographic or venographic sequence. Limited pre-contrast set of imaging sequences are sufficient to clearly identify an expansile lesion within the pulvinar of the right thalamus; a finding requiring immediate communication for action (Level I) (white arrows). It is hypointense on sagittal T1-weighted image (A) and has associated hyperintensity on axial T2-weighted FLAIR extending into the adjacent insular-opercular region (B). Even within the confines of the limited set of sequences, neoplastic differential considerations are still able to be favored over acute ischemia as no evidence of restricted diffusion is seen on diffusion-weighted imaging (DWI) sequences; specifically low signal on DWI trace images (C) and elevated diffusivity on Apparent-Diffusion-Coefficient images (not shown). Post-contrast imaging, not initially available to the readers within the limited set of review sequences, demonstrated no abnormal enhancement (D). doi:10.1371/journal.pone.0110803.g010 Figure 11 . Internal carotid artery dissection in a 41 year old male with headache. The dissection was not identified on the limited 3 sequence review. Sagittal T1-weighted image (A) shows narrowing of the distal cervical portion of the right internal carotid artery with T1 hyperintense intramural hematoma (white arrow). Axial FLAIR image (B) demonstrates loss of the normal right internal carotid artery flow void (white arrow), which is more conspicuous on the axial T2-weighted image (D). Axial diffusion weighted trace image (C) shows no restricted diffusion in the region of the right internal carotid artery. Axial precontrast T1-weighted image (E) demonstrates an eccentric T1 hyperintense intramural hematoma (white arrow) in the distal cervical right internal carotid artery. MR angiography maximum intensity projection images reveal irregular critical narrowing (white arrow) of the distal cervical right ICA (F) and asymmetrical flow-related signal in the right intracranial ICA (G). doi:10.1371/journal.pone.0110803.g011 Figure 12 . 72-year-old female with altered mental status and ischemic stroke. On the 4-sequence MRI protocol (A-D), the axial FLAIR image (B) demonstrates multifocal ill-defined areas of signal hyperintensity within the midbrain with corresponding restricted diffusion on the axial diffusion weighted trace image (C), consistent with infarctions. Additional foci of infarction were seen in the left occipital lobe, left mesial temporal lobe, both thalami and the cerebellum (images not shown). No definite abnormality is seen on the sagittal T1-weighted image (A) or axial T2* image (D). MR angiography was also requested. MRA maximum intensity projection image (E) reveals thrombus with the distal basilar (white arrow) and proximal posterior cerebral arteries, which is confirmed on the axial source MR angiography images (F, G) (white arrow). Even in retrospect, this finding was not apparent on any of the sequences included in the 4-sequence MRI protocol. MRA imaging adds significant value in cases with clinical suspicion for vascular occlusion or thrombosis. doi:10.1371/journal.pone.0110803.g012
